Comparison the Effect of Syntetice Purgative Manna Drop and Massage on Neonatal Jundic under Photothropy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016101830370N1

Enrollment

Registered

2016-11-14

Start date

2015-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal hyperbilirubinemia. Neonatal Jaundice

Interventions

Intervention 1: control group: neonatal will be received only phototherapy and standard treatment. Intervention 2: massage intervention group: infants will be received " Field" massage in addition to

B) 12 massage motions from the neck to the shoulders and reversely

C) 12 massage moves from the upper back down to the waist and reversely

D) 12 massage moves from the thighs down to the ankles and reversely

E) 12 massage motions from the shoulders to the wrists and reversely, in the middle phase, the infant was put in supine position and six extension and flexion moves were done (10 seconds for each) in

Treatment - Other

Treatment - Drugs

control group: neonatal will be received only phototherapy and standard treatment

massage intervention group: infants will be received " Field" massage in addition to conventional phototherapy." Field" Massage was performed thrice daily (morning? noon and afternoon) for 15 minutes

E) 12 massage motions from the shoulders to the wrists and reversely, in the middle phase, the infant was put in supine position and six extension and fl

Bilinaester drop intervention group: Neonatal will be treated with photothrapy and Bilinaester drop by three drops per kg three times a day

Eligibility

Sex/Gender

All

Age

2 Days to 15 Days

Inclusion criteria

Inclusion criteria: Inclusion criteria: Gestational age 35-42 week, birth weight over 2000 grams, total bilirubin12-24 mg/dl. Exclusion criteria: Indications for blood exchange transfusion, infection, asphyxia

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Unknown Hyperbilirubinemia. Timepoint: At admision. Method of measurement: Questionnaire, Laboratory Test.	—

Secondary

Measure	Time frame
Bilirubine level. Timepoint: At admision, phototherapy, discharge time. Method of measurement: At admision, phototherapy, discharge time.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Pasban

Mashhad University of Medical Sciences

pasbanf911@mums.ac.ir+98 51 3859 1513

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026